These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. HYPERTENSION AND HYPERALDOSTERONISM OF RENAL AND ADRENAL ORIGIN. SLATON PE; BIGLIERI EG Am J Med; 1965 Mar; 38():324-36. PubMed ID: 14266825 [No Abstract] [Full Text] [Related]
4. [RENAL HYPERTENSION CAUSED BY UNILATERAL AND BILATERAL KIDNEY DISEASES]. SARRE H Med Klin; 1964 May; 59():888-92. PubMed ID: 14213632 [No Abstract] [Full Text] [Related]
5. [CIRCULATORY EFFECTS OF GUANETHIDINE ON ARTERIAL PRESSURE AND RENAL FUNCTION IN HYPERTENSIVE PATIENTS STUDIED IN DECUBITUS AND STANDING POSITIONS]. RAMOS OL; AJZEN H; LIMA MC Arq Bras Cardiol; 1963 Aug; 16():209-18. PubMed ID: 14098823 [No Abstract] [Full Text] [Related]
6. EFFECT OF GUANETHIDINE AND BRETYLIUM TOSYLATE ON SYSTEMIC AND RENAL HEMODYNAMICS IN ESSENTIAL HYPERTENSION. VILLARREAL H; EXAIRE JE; RUBIO V; DAVILA H Am J Cardiol; 1964 Nov; 14():633-40. PubMed ID: 14218846 [No Abstract] [Full Text] [Related]
8. [ACUTE MALIGNANT HYPERTENSION WITH SECONDARY ALDOSTERONISM. A CASE IN A 31-YEAR-OLD MAN WITH CONGENITAL UNILATERAL RENAL HYPOPLASIA]. PEDERSEN J; LINDENEG O; FISCHER S Ugeskr Laeger; 1964 Jan; 126():73-8. PubMed ID: 14115392 [No Abstract] [Full Text] [Related]
9. [EFFECTS OF GUANETHIDINE AND RESERPINE ON EPINEPHRINE LIBERATION AND RENAL FUNCTION IN CATS]. CHU CC; WANG XL; TING KS Sheng Li Xue Bao; 1963 Jun; 26():157-64. PubMed ID: 14054090 [No Abstract] [Full Text] [Related]
10. ALDOSTERONE SECRETION RATE AND ELECTROLYTE BALANCE STUDIES ON THREE PATIENTS WITH HYPERTENSION. INFLUENCE OF GUANETHIDINE, HYDRALAZINE AND METHYCLOTHIAZIDE. SAMBHI MP; VENNING EH; BECK JC Metabolism; 1964 Mar; 13():212-20. PubMed ID: 14127688 [No Abstract] [Full Text] [Related]
11. HYPERALDOSTERONISM AND RENAL SODIUM LOSS REVERSED BY DRUG TREATMENT FOR MALIGNANT HYPERTENSION. GILL JR; GEORGE JM; SOLOMON A; BARTTER FC N Engl J Med; 1964 May; 270():1088-92. PubMed ID: 14129058 [No Abstract] [Full Text] [Related]
12. [ANTIHYPERTENSIVE PROPERTIES OF A MONOAMINE OXIDASE INHIBITOR (DL-SERINE-N2-ISOPROPYLHYDRAZIDE: RO 4-1038). CLINICAL RESULTS AND EFFECT ON RENAL FUNCTION]. TEUSCHER A; LUGINBUEHL H Cardiologia (Basel); 1964; 45():1-20. PubMed ID: 14162398 [No Abstract] [Full Text] [Related]
13. [ARTERIAL HYPERTENSION CAUSED BY LESION TO THE RENAL ARTERIES]. TCHERDAKOFF P; MEYER P; SAMARCQ P; MILLIEZ P J Urol Nephrol (Paris); 1964; 70():699-711. PubMed ID: 14205989 [No Abstract] [Full Text] [Related]
14. GUANETHIDINE AND METHYLDOPA: A HAEMODYNAMIC STUDY. CHAMBERLAIN DA; HOWARD J Br Heart J; 1964 Jul; 26(4):528-36. PubMed ID: 14196136 [No Abstract] [Full Text] [Related]
15. EFFECT OF DIET, POSTURE, AND GUANETHIDINE ON TCH2O IN HYPERTENSIVE SUBJECTS. RAMOS OL; AJZEN H; LIMA MC J Appl Physiol; 1964 Nov; 19():1175-8. PubMed ID: 14232315 [No Abstract] [Full Text] [Related]
19. THE ANGIOTENSIN-INFUSION TEST. A NEW APPROACH TO THE DIFFERENTIAL DIAGNOSIS OF RENOVASCULAR HYPERTENSION. KAPLAN NM; SILAH JG N Engl J Med; 1964 Sep; 271():536-41. PubMed ID: 14172470 [No Abstract] [Full Text] [Related]
20. [METHODS OF INVESTIGATION OF HYPERTENSION OF RENAL ORIGIN]. VERNIORY A Brux Med; 1964 Apr; 44():379-92. PubMed ID: 14146790 [No Abstract] [Full Text] [Related] [Next] [New Search]